BioCentury
ARTICLE | Strategy

Share not, want not

October 23, 2006 7:00 AM UTC

With sales of erectile dysfunction drug Cialis tadalafil ramping up and the prospect of add-on indications on the horizon, Eli Lilly and Co. decided it was time to stop sharing the business with Icos. Corp.

As a result, the companies last week announced that LLY would acquire its biotech partner for $32 per share, or about $2.1 billion in cash...